mg±ùÇòÍ»ÆƹÙÍøÍøÕ¾

OAÈë¿Ú
±¨¸æµ¥ÅÌÎÊ
ÔÚÏß¿Í·þ
mg±ùÇòÍ»ÆÆ(ÖйúÓÎ)¹Ù·½ÍøÕ¾
ÐÂÎÅÖÐÐÄ
News Center
Èð½ðÒ½ÔºÉñ¾­ÄÚ¿ÆÓëmg±ùÇòÍ»ÆƹÙÍøÍøÕ¾ºÏ×÷ £¬ÍƽøÖйúÓÐÊý×ÔÉíÃâÒßÐÔÄÔÑ×Ñо¿
Ðû²¼£º2024/05/31
¿ËÈÕ £¬mg±ùÇòÍ»ÆƹÙÍøÍøÕ¾¼ÓÈëµÄ¡°º£ÄÚ¿¹DPPXÄÔÑ׶àÖÐÐÄÑо¿¡±Ð§¹û½ÒÏþÓÚ¹ú¼ÊÆÚ¿¯¡¶Frontiers in Neuroscience¡·£¨IF=5.152£©[1] £¬×ܽáÁ˼²²¡µÄÁÙ´²ÌåÏÖ¡¢Ó°Ïñѧ¼ì²é¼°·¢²¡ÒòËØ¡¢ÖÎÁÆÊֶεÈÐÅÏ¢ £¬ÎªÎ´À´¿¹DPPXÄÔÑ×µÄÕï¶ÏºÍÖÎÁÆÌṩÁËеÄÊӽǡ£


¸Ã¶àÖÐÐÄÑо¿ÏîÄ¿ÓÉÉϺ£½»Í¨´óѧҽѧԺÁ¥ÊôÈð½ðÒ½ÔºÉñ¾­ÄÚ¿ÆÍŶÓǣͷ £¬Õã½­´óѧҽѧԺÁ¥ÊôµÚ¶þÒ½Ôº¡¢Õ㽭ʡ̨ÖÝÒ½Ôº¡¢¸´µ©´óѧÁ¥Êô»ª¶«Ò½Ôº¡¢º¼ÖÝÊеÚÒ»ÈËÃñÒ½Ôº¡¢¼ÎÐË´óѧÁ¥ÊôµÚ¶þÒ½Ôº¡¢°ö²ºÒ½¿Æ´óѧµÚÒ»Á¥ÊôÒ½Ôº¡¢ÓÀ¿µÊеÚÒ»ÈËÃñÒ½Ôº¡¢ÓÀ¿µÊÐÖÐÒ½Ôº¡¢ÉϺ£ÊеÚÒ»ÈËÃñÒ½ÔºµÈ¾ÅËùÒ½ÔºÅäºÏ¼ÓÈë¡£

ͼƬ1.png

ÂÛÎÄÐû²¼½Øͼ


¿¹DPPXÄÔÑ×ÊÇз¢Ã÷µÄ½ÏÓÐÊýµÄ×ÔÉíÃâÒßÐÔÄÔÑ× £¬ÓÉBoronat¼´ÊÇ2013ÄêÂÊÏȱ¨¸æ[2] £¬Èð½ðÒ½ÔºÓÚ2019Ä걨¸æÎÒ¹ú»¼Õß[3,4]¡£DPPXÊÇÒ»ÖÖ¼ØͨµÀKv4.2Ñǵ¥Î»µ÷ÀíÂÑ°× £¬ÆÕ±éÂþÑÜÓÚÖÐÊàÉñ¾­ÏµÍ³Éñ¾­Ôª°ûÌåºÍÊ÷Í» £¬»¹ÂþÑÜÓÚ³¦µÀÉñ¾­½ÚÖС£¸Ã¿¹ÌåÀàÐÍÄÔÑ׵䷶ÌåÏÖ³ýÖÐÊàÉñ¾­ÏµÍ³Ì«¹ýÐË·Ü¡¢ÈÏÖª/¾«ÉñÕÏ°­Íâ £¬»¹»áÓи¹Í´¡¢¸¹ÐººÍÌåÖؼõÇáµÈ¶àÖÖÖ¢×´[4]¡£



Ñо¿ÄÚÈÝ


¸ÃÑо¿ÍøÂç²¢ÆÊÎöÁË2021Äê3ÔÂÖÁ2023Äê6ÔÂʱ´ú¾ÍÕïµÄ14Ãû»¼ÕßµÄÁÙ´²Ö¢×´¡¢¿¹ÌåЧ¹û¡¢Ó°ÏñÐÅÏ¢ºÍÖÎÁÆÔ¤ºóµÈÐÅÏ¢¡£Ñо¿·¢Ã÷£º¿¹DPPXÄÔÑ×»¼ÕßµÄÖÐλÄêËêΪ46Ë꣨11~72Ë꣩ £¬ÄÐÐÔÕ¼´ó¶¼£¨9/14£©¡£Ö÷ÒªÖ¢×´°üÀ¨ÈÏÖªÕÏ°­£¨7/14£©£»ÖÐÊàÉñ¾­ÏµÍ³ÐË·Ü·ÜÐÔ£¨6/14£© £¬È磺¼¡ÕóÂΡ¢ñ²ðﱬ·¢ºÍÖ«Ìå³é´¤£»Î¸³¦¹¦Ð§ÕÏ°­£¨5/14£©£»¾«ÉñÕÏ°­£¨5/14£© £¬È磺»Ã¾õºÍ¾«ÉñÐÐΪÒì³£¡£Í¬Ê±Ò²·¢Ã÷¸ü²»³£¼ûµÄÖ¢×´£ºË¯ÃßÕÏ°­£¨2/14£© £¬ÑÓËè×ÛºÏÕ÷£¨1/14£© £¬ñ²ð2/14£©¡£

·ºÆðË«ÖØ¿¹Éñ¾­Ôª¿¹ÌåÑôÐÔ

ÓÐ2Ãû»¼Õß·ºÆðDPPX¿¹ÌåÓëÆäËû×ÔÉíÃâÒß¿¹Ìå¹²´æ¡£ÆäÖл¼Õß13µÄѪÇ忹DPPX¿¹ÌåºÍ¿¹NMDAR¿¹Ìå¾ù³ÊÑôÐÔ £¬µÎ¶È»®·ÖΪ1£º100ºÍ1£º32 £¬Ö÷Ҫ֢״Ϊ¸¹Ðº¡¢¼¡Èâ¾·ÂΡ¢¸ÐÊÜÒì³£µÈ¡£ÆäÇкϿ¹DPPXÄÔÑ×ÌØÕ÷ÐÔÌåÏÖ £¬ÇÒDPPX¿¹ÌåµÎ¶È¸ü¸ß £¬Ë¼Á¿Õï¶ÏÆäΪ¿¹DPPXÄÔÑס£Ë«ÖØ¿¹Éñ¾­Ôª¿¹ÌåÑôÐÔAE £¬»¼ÕßµÄÁÙ´²ÌåÏÖ¡¢Ö²¡»úÖÆ¡¢¶ÔÖÎÁƵķ´Ó¦¾ù¿ÉÄܱ¬·¢×ª±ä¡£Òò´Ë £¬Ó¦¾ÙÐÐÏà¹ØÉñ¾­Ôª¿¹ÌåµÄÖÜȫɸ²é £¬¾¡¿ìÃ÷È·Õï¶Ï¡£

Ó°ÏñѧÌØÕ÷

42.9%µÄ»¼ÕßÓÐMRIÒì³£ £¬°üÀ¨Æ¤ÖÊÔöÇ¿¡¢°×Öʸı䡢º£ÂíÖ×ÕÍ»òήËõÒÔ¼°Ð¡ÄÔήËõ¡£2Àý»¼Õß18F-FDG PET/MRIÌåÏÖΪò¨Ò¶¼°ÇðÄԵʹúл £¬Ó뻼ÕßÁÙ´²Ö¢×´Ò»Ö¡£¿¹DPPX¿¹ÌåÄÔÑ×»¼ÕßMRI¶àÎÞÌØÒìÐÔ [5] £¬18F¡ªFDG PET¶ÔÃ÷È·¿¹DPPX¿¹ÌåÄÔÑ×­ÄÚ´úлģʽ¡¢Ìá¸ßÑôÐÔ¼ì³öÂÊ¿ÉÄÜÓÐËù×ÊÖú[2]¡£

ͼƬ2.png

¿¹DPPXÄÔÑ×»¼ÕßµÄÉñ¾­Ó°ÏñѧÌåÏÖ¡£(A £¬B)12ÀýÈÏÖªÕÏ°­»¼ÕߴŹ²Õñ³ÉÏñ(MRI)ÏÔʾ×ó²àº£ÂíήËõ £¬Õýµç×Ó·¢Éä¶Ï²ãɨÃèÏÔʾ×ó²àº£Âí18F-·úÍÑÑõÆÏÌÑÌÇ(FDG)ÉãÈ¡ïÔÌ­(Õýµç×Ó·¢Éä¶Ï²ãɨÃè)/ºË´Å¹²Õñ³ÉÏñ¡£13ÀýÈÏÖª¹¦Ð§ÕÏ°­»¼ÕßÔÚPET/MRI¹Ú״λ(E £¬F)ÖáλºÍʸ״λ(G £¬H)ÏÔʾ˫²àò¨Ò¶1¡ãF-FDGÉãÈ¡ïÔÌ­¡£(1,J)¹²¼Ãʧµ÷»¼Õß14ÀýMRIÏÔʾСÄÔήËõ¡£

ͼƬ3.png

ѪÇå¼°ÄÔ¼¹ÒºÖÐDPPX¿¹Ìå¼ì²â³ÊÑôÐÔ¡£(A) CBA·¨-»¼ÕßѪÇå¼°ÄÔ¼¹ÒºÑù±¾¼ì²âÓ«¹âЧ¹ûͼ£»(B) TBA-»ùÓÚº£Âí¡¢Ð¡ÄÔ×éÖ¯ÇÐƬӫ¹âЧ¹ûͼ¡£



Ñо¿Ð¡½á


Éñ¾­ÏµÍ³ºÍÃâÒßϵͳ֮¼ä´í×ÛÖØ´óµÄÏ໥×÷ÓÃÉ漰ϸÃܵÄÐźÅת´ï¡¢Ï¸°ûǨáãºÍÃâÒßµ÷ÀíÀú³Ì £¬ÓÕ·¢µÄÁÙ´²ÌåÏÖ¸üÊǶàÑùÐÔÇÒ·ÇÌØÒìÐÔ¡£mg±ùÇòÍ»ÆƹÙÍøÍøÕ¾Ó뺣ÄÚÉñ¾­¿Æѧר¼ÒµÄÐÂÑо¿ £¬Îª¿¹DPPXÄÔÑ×µÄÁÙ´²ÌØÕ÷ÌṩÁËеĿÆѧ֤¾Ý £¬Íƶ¯Á˾«×¼Ò½ÁƵÄÇ°½ø¡£


mg±ùÇòÍ»ÆƹÙÍøÍøÕ¾Éñ¾­&ÃâÒß¼²²¡ÖÐÐÄרעÓÚÉñ¾­ÏµÍ³¼²²¡µÄ¼ì²âÊÖÒÕÁ¢Òì¡¢ÏîÄ¿·õ»¯¼°ÁÙ´²Ó¦Óá£ÒÀÍнṹÌìϵÄÁ¬Ëø»¯Ò½Ñ§ÊµÑéÊҺͿçÇøÓòר¿ÆͬÃ˵ÄÓÅÊÆ £¬¸ÃÖÐÐĽô¸ú¿¹Ìå¼ì²â¿Æ¼¼Ç°ÑØ £¬ÀýÈçÍƳöMOG-IgG»îϸ°û¼ì²â·¨ £¬×ÛºÏÉñÃâ¼ì²âÊÖÒÕƽ̨ £¬ÒÑÀÖ³ÉÅбð³öÉÏ°ÙÖÖÓÐÊý¿¹Éñ¾­Ôª¿¹Ìå £¬ÎªÌ½Ë÷δ֪µÄÐÂÐÍ¿¹Ìå¡¢¿ªÕ¹´ó¹æÄ£Éñ¾­ÃâÒß¼²²¡Ñо¿µÓÚ¨Á˼áʵµÄÊý¾Ý»ùʯ¡£


ÒÀ¸½¸»ºñµÄ¼ì²â·þÎñÓëʵÑéÊÒÔËÓªÂÄÀú £¬mg±ùÇòÍ»ÆƹÙÍøÍøÕ¾ÕýÒ»Á¬Íƶ¯Éñ¾­¼²²¡Õï¶ÏÁ÷³ÌµÄ±ê×¼»¯Àú³Ì £¬ÌáÉýÐÐÒµ·þÎñˮƽ¡£



²Î¿¼ÎÄÏ×


[1] Gao Y, Zhang Y, Chunyu H, et al. Expanding the clinical spectrum of anti-DPPX encephalitis: a multicenter retrospective study. Front. Neurosci. 18:1379933.

[2] Boronat A, Gelfand JM, GresaArribas N, et al. Encephalitis and antibodies to dipeptidylpeptidaselike protein6, a subunit of Kv4.2 potassium channels[J]. Ann Neurol, 2013, 73(1): 120128.

[3] Zhou Q, Zhu X, Meng H, et al. Anti-dipeptidyl-peptidase-like protein 6 encephalitis, a rare cause of reversible rapid progressive dementia and insomnia. J Neuroimmunol. 2020 Feb 15;339:577114.

[4] ÖÜÇÚÃ÷,²ÌÓÂ,ÄßÓÅ,µÈ. ¿¹¶þëÄ»ùëÄøÑùÂÑ°×-6¿¹ÌåÄÔÑ×[J].ÖйúÏÖ´úÉñ¾­¼²²¡ÔÓÖ¾,2020,20(10):862-867.

[5] ÖлªÒ½Ñ§»áÉñ¾­²¡Ñ§·Ö»áÉñ¾­Ñ¬È¾ÐÔ¼²²¡ÓëÄÔ¼¹ÒºÏ¸°ûѧѧ×é. Öйú×ÔÉíÃâÒßÐÔÄÔÑ×ÕïÖÎר¼Ò¹²Ê¶£¨2022Äê°æ£©[J]. ÖлªÉñ¾­¿ÆÔÓÖ¾, 2022, 55(9): 931-949.

[6] Hara, M., Ari?o, H., Petit-Pedrol, M., et al. DPPX antibody-associated encephalitis: Main syndrome and antibody effects. Neurology 88, 1340¨C1348.



ÍøÕ¾µØͼ